149 related articles for article (PubMed ID: 31266825)
1. A Randomized Controlled Trial Testing Provision of Fecal and Blood Test Options on Participation for Colorectal Cancer Screening.
Symonds EL; Hughes D; Flight I; Woodman R; Chen G; Ratcliffe J; Pedersen SK; Fraser RJL; Wilson CJ; Young GP
Cancer Prev Res (Phila); 2019 Sep; 12(9):631-640. PubMed ID: 31266825
[TBL] [Abstract][Full Text] [Related]
2. "Rescue" of Nonparticipants in Colorectal Cancer Screening: A Randomized Controlled Trial of Three Noninvasive Test Options.
Young GP; Chen G; Wilson CJ; McGrane E; Hughes-Barton DL; Flight IHK; Symonds EL
Cancer Prev Res (Phila); 2021 Aug; 14(8):803-810. PubMed ID: 34127509
[TBL] [Abstract][Full Text] [Related]
3. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
5. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
6. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
[TBL] [Abstract][Full Text] [Related]
7. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
8. Detection of Colorectal Neoplasia in a Cohort Before and After the Change of Fecal Occult Blood Test in a French Colorectal Cancer Screening Program.
Koïvogui A; Mab GL; Benamouzig R
Am J Gastroenterol; 2018 Dec; 113(12):1891-1899. PubMed ID: 30337703
[TBL] [Abstract][Full Text] [Related]
9. Improving Participation in Colorectal Cancer Screening: a Randomised Controlled Trial of Sequential Offers of Faecal then Blood Based Non-Invasive Tests.
Symonds EL; Pedersen S; Cole SR; Massolino J; Byrne D; Guy J; Backhouse P; Fraser RJ; LaPointe L; Young GP
Asian Pac J Cancer Prev; 2015; 16(18):8455-60. PubMed ID: 26745101
[TBL] [Abstract][Full Text] [Related]
10. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
11. Patterns of participation over four rounds of annual fecal immunochemical test-based screening for colorectal cancer: what predicts rescreening?
Osborne JM; Wilson C; Duncan A; Cole SR; Flight I; Turnbull D; Hughes DL; Young GP
BMC Public Health; 2017 Aug; 18(1):81. PubMed ID: 28764667
[TBL] [Abstract][Full Text] [Related]
12. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
[TBL] [Abstract][Full Text] [Related]
13. The role of area-level deprivation and gender in participation in population-based faecal immunochemical test (FIT) colorectal cancer screening.
Clarke N; McNamara D; Kearney PM; O'Morain CA; Shearer N; Sharp L
Prev Med; 2016 Dec; 93():198-203. PubMed ID: 27765660
[TBL] [Abstract][Full Text] [Related]
14. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Colorectal Cancer Screening Participation in Southern Khorasan (Iran).
Ramazani AA; Norozi E; AmirabadiZadeh H; Ehteshampour AR; Salehiniya H
J Gastrointest Cancer; 2021 Mar; 52(1):187-191. PubMed ID: 32125621
[TBL] [Abstract][Full Text] [Related]
16. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
17. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
Grobbee EJ; van der Vlugt M; van Vuuren AJ; Stroobants AK; Mundt MW; Spijker WJ; Bongers EJC; Kuipers EJ; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E; Spaander MCW
Gut; 2017 Nov; 66(11):1975-1982. PubMed ID: 27507905
[TBL] [Abstract][Full Text] [Related]
18. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study.
Coronado GD; Thompson JH; Petrik AF; Nyongesa DB; Leo MC; Castillo M; Younger B; Escaron A; Chen A
J Am Board Fam Med; 2019; 32(3):318-328. PubMed ID: 31068396
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Controlled Trial of Opt-in Versus Opt-Out Colorectal Cancer Screening Outreach.
Mehta SJ; Khan T; Guerra C; Reitz C; McAuliffe T; Volpp KG; Asch DA; Doubeni CA
Am J Gastroenterol; 2018 Dec; 113(12):1848-1854. PubMed ID: 29925915
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the OC Sensor
Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
